Within the Agency, the Committee for Advanced Therapies has the appropriate expertise for the examination of quality and non-clinical data relating to advanced therapy medicinal products. It should therefore be responsible for evaluating applications for certification.
Recital 5, Commission Regulation (EC) No 668/2009 of 24 July 2009 implementing Regulation (EC) No 1…
In forcesince 24 Jul 2009